Search filters

List of works by François Bertucci

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

scientific article published on 06 January 2020

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

scientific article published on 18 October 2013

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

scientific article published on 4 May 2017

Alterations of polycomb gene BMI1 in human myeloproliferative neoplasms ⬇️

scientific article published on July 24, 2012

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells

scientific article published on 02 February 2022

CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction ⬇️

scientific article published on October 31, 2011

Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors

scientific article published on March 1, 2011

Clinical Application of Proteomics in Breast Cancer: State of the Art and Perspectives ⬇️

scientific article published on December 13, 2010

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

scientific article published on 18 January 2022

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.

scientific article published in November 2011

Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02) ⬇️

scientific article published on September 15, 2012

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

scientific article published on 21 September 2010

Dramatic and Delayed Response to Doxorubicin-Dacarbazine Chemotherapy of a Giant Desmoid Tumor: Case Report and Literature Review ⬇️

scientific article published on March 5, 2013

EFA6B regulates a stop signal for collective invasion in breast cancer

scientific article published on 13 April 2021

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review ⬇️

scientific article published on October 4, 2011

Endometriosis-Associated Ovarian Carcinomas ⬇️

scientific article published on 01 February 2011

Gene Expression Profiling forIn SilicoMicrodissection of Hodgkin's Lymphoma Microenvironment and Identification of Prognostic Features ⬇️

scientific article published on December 13, 2010

Gene Expression Profiling of Solitary Fibrous Tumors ⬇️

scientific article published on May 29, 2013

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease

scientific article

High incidence of asymptomatic renal cancer in late survivors after heart transplantation ⬇️

scientific article published on May 31, 2011

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors

scientific article published on 01 June 2022

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial

scientific article published on 05 March 2018

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

scientific article published on 11 February 2015

LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma

scientific article published on 19 August 2021

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion

scientific article published on 27 August 2021

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

scientific article

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

scientific article published on 11 December 2015

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

scientific article

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms ⬇️

scientific article published on April 9, 2012

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers

scientific article published on 05 February 2020

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

scientific article

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

scientific article published on 27 July 2015

Pancreatic metastasis from osteosarcoma and Ewing sarcoma: literature review ⬇️

scientific article published on 06 August 2012

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

scientific article published on 19 July 2019

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

scientific article published on 5 April 2016

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

scientific article published on 04 December 2020

Primary leiomyosarcoma of the seminal vesicle: Case report and review of the literature ⬇️

scientific article published on July 29, 2011

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

scientific article published on 11 October 2018

REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis

scientific article published on 10 March 2017

Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study

scientific article published on 19 July 2019

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

scientific article published on 14 October 2016

Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years

scientific article published on 15 April 2019

Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.

scientific article

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

scientific article

Soft tissue sarcomas: clinical application of molecular biology

scholarly article by Bruno Chetaille published in March 2013

Solitary Fibrous Tumor of the Prostate: Case Report and Review of the Literature ⬇️

scientific article published on January 10, 2012

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

scientific article published on 20 July 2017

The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer

scientific article published on 05 May 2021

The off-label use of targeted therapies in sarcomas: the OUTC'S program

scientific article

The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype

scientific article published on 06 March 2020

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

scientific article

Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group

scientific article

Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma

scientific article published on 05 February 2021

Paulina is supported by:

About Paulina

Help